News

The Drug Supply Chain Security Act creates uncertainty about which trading partners have responsibility for product verification

Modern training technologies make the prospect of days-long training courses an obsolete practice

Real-world data sources can provide new dimensions to marketing plans

Latest ZS AccessMonitor asks, 'Who are physicians listening to?'

First to gain newly established program reviewing therapy management and chronic care

Vaccine working group tries to build consensus on temperature control and dispensing practices

Outsourced contract-administration provider highlights growth in invoicing and financial stewardship burdens

Meanwhile, competitor CSafe Global broadens its containers' usability

The drive for lower costs, safer products

Picks up Gallus Pharma, whose plants are in St. Louis and Princeton, NJ

Securing your supply chain

MolecularHealth's RxAssistance evaluates patient access to commercial therapeutics and clinical trials

True 'market access' should involve coordinated approaches to patients and their healthcare providers

MDM practices are moving far beyond compliance concerns

American Airlines and India's Menzies Aviation Bobba build cold chain capacity

$8.3-billion deal is Roche’s biggest since acquiring Genentech in 2009

Cloud-based system is intended to focus reps' sales efforts more effectively

Now, CMS will publish 66% of received data on Sept. 30

Company handles distribution of 'niche' blood, chemotherapy and specialty products

Company handles distribution of 'niche' blood, chemotherapy and specialty products

The widely prescribed products will have some supply chain hiccups

Company's Ingenuity Health service monitors Seroquel XR, Abilify usage

TrialRx service analyzes and mitigates disclosure risks

Will federal legislation resolve ongoing DEA/drug-distributor conflicts?

Meanwhile, a scramble to accelerate vaccine testing ramps up

Absence of agreed-on FDA guidance keeps biosimilars off the US market even as their use grows abroad

Three times as many manufacturers expect more 3PL use as expect less; 38% see no change